Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Cash & Current Investments: 2018-2024

Historic Cash & Current Investments for CureVac N.V (CVAC) over the last 7 years, with Dec 2024 value amounting to $518.7 million.

  • CureVac N.V's Cash & Current Investments rose 101.72% to $448.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.0 billion, marking a year-over-year increase of 36.33%. This contributed to the annual value of $518.7 million for FY2024, which is 18.99% up from last year.
  • According to the latest figures from FY2024, CureVac N.V's Cash & Current Investments is $518.7 million, which was up 18.99% from $435.9 million recorded in FY2023.
  • Over the past 5 years, CureVac N.V's Cash & Current Investments peaked at $1.6 billion during FY2020, and registered a low of $435.9 million during FY2023.
  • Moreover, its 3-year median value for Cash & Current Investments was $510.4 million (2022), whereas its average is $488.3 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first spiked by 4,341.10% in 2020, then plummeted by 45.33% in 2022.
  • Yearly analysis of 5 years shows CureVac N.V's Cash & Current Investments stood at $1.6 billion in 2020, then tumbled by 40.91% to $933.6 million in 2021, then tumbled by 45.33% to $510.4 million in 2022, then dropped by 14.60% to $435.9 million in 2023, then grew by 18.99% to $518.7 million in 2024.